Somatostatin Subtype‑2 Receptor-Targeted Metal-Based Anticancer Complexes

Conjugates of a dicarba analogue of octreotide, a potent somatostatin agonist whose receptors are overexpressed on tumor cells, with [PtCl2(dap)] (dap = 1-(carboxylic acid)-1,2-diaminoethane) (3), [(η6-bip)Os(4-CO2-pico)Cl] (bip = biphenyl, pico = picolinate) (4), [(η6-p-cym)RuCl(dap)]+ (p-cym = p-cymene) (5), and [(η6-p-cym)RuCl(imidazole-CO2H)(PPh3)]+ (6), were synthesized by using a solid-phase approach. Conjugates 35 readily underwent hydrolysis and DNA binding, whereas conjugate 6 was inert to ligand substitution. NMR spectroscopy and molecular dynamics calculations showed that conjugate formation does not perturb the overall peptide structure. Only 6 exhibited antiproliferative activity in human tumor cells (IC50 = 63 ± 2 μM in MCF-7 cells and IC50 = 26 ± 3 μM in DU-145 cells) with active participation of somatostatin receptors in cellular uptake. Similar cytotoxic activity was found in a normal cell line (IC50 = 45 ± 2.6 μM in CHO cells), which can be attributed to a similar level of expression of somatostatin subtype-2 receptor. These studies provide new insights into the effect of receptor-binding peptide conjugation on the activity of metal-based anticancer drugs, and demonstrate the potential of such hybrid compounds to target tumor cells specifically.

A aldraxe proverbial da preguiza nas dúas versións españolas de The Way to Wealth de Benjamin Franklin

A admiración que destilou no seu tempo e durante o século XIX o bo sentido común das obras de Benjamin Franklin (1706-1790) plasmouse na tradución dos seus libros a un considerable número de linguas. The Way to Wealth (El camino de la fortuna o Cómo hacerse rico), publicado en 1758, contén máis de cen máximas que instan ao traballo honrado, á orde e ao aforro, condenando calquera sinal de preguiza ou desidia. O noso corpus nútrese dunha selección de trece aforismos que teñen relación precisamente con este vicio que condena á miseria, a preguiza. En cambio, o home de ben que aplique as virtudes contidas en The Way to Wealth, aconselladas a modo de refráns, verá, segundo o autor, prosperar esplendidamente a súa economía. Pretendemos analizar, dende os puntos de vista tradutolóxico e contrastivo, o corpus de dúas traducións españolas deste libriño de Franklin: unha anónima, publicada en Barcelona, en 1891; e a de Alberto Lena de 1999.

Top manta: escenario actual y perspectiva de futuro

1. Como consecuencia de la LO 5/2010 se ha introducido en el art. 270 CP un segundo párrafo, con el objeto de solucionar los supuestos conocidos como “top manta”, esto es, venta callejera de CD y DVD reproducidos ilegalmente. Para un creciente sector de la doctrina3 y la jurisprudencia tales supuestos eran (o debían ser) atípicos, por tres razones: a) se trataría de supuestos en los que el perjuicio ocasionado al titular de los derechos de explotación de la obra es reducido, dado el escaso número de copias que se distribuyen (principios de proporcionalidad, fragmentariedad y subsidiariedad del Derecho penal con respecto al Derecho administrativo);4 b) el concepto de distribución previsto en el art. 19 LPI no comprende la venta al detalle, sino sólo la distribución a gran escala, por lo que es necesaria una mínima estructura organizativa que en los casos de top manta no concurre;5 c) ausencia de engaño en el consumidor, dado el carácter burdo de las copias.

Conjugation of a Ru(II) Arene Complex to Neomycin or to Guanidinoneomycin Leads to Compounds with Differential Cytotoxicities and Accumulation between Cancer and Normal Cells

A straightforward methodology for the synthesis of conjugates between a cytotoxic organometallic ruthenium(II) complex and amino- and guanidinoglycosides, as potential RNA-targeted anticancer compounds, is described. Under microwave irradiation, the imidazole ligand incorporated on the aminoglycoside moiety (neamine or neomycin) was found to replace one triphenylphosphine ligand from the ruthenium precursor [(η6-p-cym)RuCl(PPh3)2]+, allowing the assembly of the target conjugates. The guanidinylated analogue was easily prepared from the neomycin-ruthenium conjugate by reaction with N,N′-di-Boc-N″-triflylguanidine, a powerful guanidinylating reagent that was compatible with the integrity of the metal complex. All conjugates were purified by semipreparative high-performance liquid chromatography (HPLC) and characterized by electrospray ionization (ESI) and matrix-assisted laser desorptionionization time-of-flight (MALDI-TOF) mass spectrometry (MS) and NMR spectroscopy. The cytotoxicity of the compounds was tested in MCF-7 (breast) and DU-145 (prostate) human cancer cells, as well as in the normal HEK293 (Human Embryonic Kidney) cell line, revealing a dependence on the nature of the glycoside moiety and the type of cell (cancer or healthy). Indeed, the neomycinruthenium conjugate (2) displayed moderate antiproliferative activity in both cancer cell lines (IC50 ≈ 80 μM), whereas the neamine conjugate (4) was inactive (IC50 ≈ 200 μM). However, the guanidinylated analogue of the neomycinruthenium conjugate (3) required much lower concentrations than the parent conjugate for equal effect (IC50 = 7.17 μM in DU-145 and IC50 = 11.33 μM in MCF-7). Although the same ranking in antiproliferative activity was found in the nontumorigenic cell line (3 2 > 4), IC50 values indicate that aminoglycoside-containing conjugates are about 2-fold more cytotoxic in normal cells (e.g., IC50 = 49.4 μM for 2) than in cancer cells, whereas an opposite tendency was found with the guanidinylated conjugate, since its cytotoxicity in the normal cell line (IC50 = 12.75 μM for 3) was similar or even lower than that found in MCF-7 and DU-145 cancer cell lines, respectively. Cell uptake studies performed by ICP-MS with conjugates 2 and 3 revealed that guanidinylation of the neomycin moiety had a positive effect on accumulation (about 3-fold higher in DU-145 and 4-fold higher in HEK293), which correlates well with the higher antiproliferative activity of 3. Interestingly, despite the slightly higher accumulation in the normal cell than in the cancer cell line (about 1.4-fold), guanidinoneomycinruthenium conjugate (3) was more cytotoxic to cancer cells (about 1.8-fold), whereas the opposite tendency applied for neomycinruthenium conjugate (2). Such differences in cytotoxic activity and cellular accumulation between cancer and normal cells open the way to the creation of more selective, less toxic anticancer metallodrugs by conjugating cytotoxic metal-based complexes such as ruthenium(II) arene derivatives to guanidinoglycosides.

Cuestiones sobre el contrato de servicios diseñado en el Marco Común de Referencia

La reciente publicación del draft del Common Frame of Reference invita a reflexionar sobre la figura del contrato de servicios, tal como ha sido desarrollada por el Study Group on a European Civil Code, y respecto de la que encontramos verdaderas innovaciones en comparación con la teoría tradicional que aún mantienen nuestra doctrina y jurisprudencia. El objeto del trabajo es exponer algunas de las soluciones que propone el derecho contractual europeo, e incidir en la posibilidad y conveniencia de su aplicación en nuestro país, con vistas a la oportuna elaboración de la tan esperada regulación civil sobre el contrato de servicios.

Complexes of Pd(II) and Pt(II) with 9-aminoacridine: reactions with DNA and study of their antiproliferative activity

Four new metal complexes {M = Pd(II) or Pt(II)} containing the ligand 9-aminoacridine (9AA) were prepared. The compounds were characterized by FT-IR and 1H, 13C, and 195Pt NMR spectroscopies. Crystal structure of the palladium complex of formulae [Pd(9AA)(μ-Cl)]2 · 2DMF was determined by X-ray diffraction. Two 9-acridine molecules in the imine form bind symmetrically to the metal ions in a bidentate fashion through the imine nitrogen atom and the C(1) atom of the aminoacridine closing a new five-membered ring. By reaction with phosphine or pyridine, the Cl bridges broke and compounds with general formulae [Pd(9AA)Cl(L)] (where L = PPh3 or py) were formed. A mononuclear complex of platinum of formulae [Pt(9AA)Cl(DMSO)] was also obtained by direct reaction of 9-aminoacridine and the complex [PtCl2(DMSO)2]. The capacity of the compounds to modify the secondary and tertiary structures of DNA was evaluated by means of circular dichroism and electrophoretic mobility. Both palladium and platinum compounds proved active in the modification of both the secondary and tertiary DNA structures. AFM images showed noticeable modifications of the morphology of the plasmid pBR322 DNA by the compounds probably due to the intercalation of the complexes between base pairs of the DNA molecule. Finally, the palladium complex was tested for antiproliferative activity against three different human tumor cell lines. The results suggest that the palladium complex of formula [Pd(9AA)(μ-Cl)]2 has significant antiproliferative activity, although it is less active than cisplatin.

Complexes of Pd(II) and Pt(II) with 9-aminoacridine: reactions with DNA and study of their antiproliferative activity

Four new metal complexes {M = Pd(II) or Pt(II)} containing the ligand 9-aminoacridine (9AA) were prepared. The compounds were characterized by FT-IR and 1H, 13C, and 195Pt NMR spectroscopies. Crystal structure of the palladium complex of formulae [Pd(9AA)(μ-Cl)]2 · 2DMF was determined by X-ray diffraction. Two 9-acridine molecules in the imine form bind symmetrically to the metal ions in a bidentate fashion through the imine nitrogen atom and the C(1) atom of the aminoacridine closing a new five-membered ring. By reaction with phosphine or pyridine, the Cl bridges broke and compounds with general formulae [Pd(9AA)Cl(L)] (where L = PPh3 or py) were formed. A mononuclear complex of platinum of formulae [Pt(9AA)Cl(DMSO)] was also obtained by direct reaction of 9-aminoacridine and the complex [PtCl2(DMSO)2]. The capacity of the compounds to modify the secondary and tertiary structures of DNA was evaluated by means of circular dichroism and electrophoretic mobility. Both palladium and platinum compounds proved active in the modification of both the secondary and tertiary DNA structures. AFM images showed noticeable modifications of the morphology of the plasmid pBR322 DNA by the compounds probably due to the intercalation of the complexes between base pairs of the DNA molecule. Finally, the palladium complex was tested for antiproliferative activity against three different human tumor cell lines. The results suggest that the palladium complex of formula [Pd(9AA)(μ-Cl)]2 has significant antiproliferative activity, although it is less active than cisplatin.

Complexes of Pd(II) and Pt(II) with 9-aminoacridine: reactions with DNA and study of their antiproliferative activity

Four new metal complexes {M = Pd(II) or Pt(II)} containing the ligand 9-aminoacridine (9AA) were prepared. The compounds were characterized by FT-IR and 1H, 13C, and 195Pt NMR spectroscopies. Crystal structure of the palladium complex of formulae [Pd(9AA)(μ-Cl)]2 · 2DMF was determined by X-ray diffraction. Two 9-acridine molecules in the imine form bind symmetrically to the metal ions in a bidentate fashion through the imine nitrogen atom and the C(1) atom of the aminoacridine closing a new five-membered ring. By reaction with phosphine or pyridine, the Cl bridges broke and compounds with general formulae [Pd(9AA)Cl(L)] (where L = PPh3 or py) were formed. A mononuclear complex of platinum of formulae [Pt(9AA)Cl(DMSO)] was also obtained by direct reaction of 9-aminoacridine and the complex [PtCl2(DMSO)2]. The capacity of the compounds to modify the secondary and tertiary structures of DNA was evaluated by means of circular dichroism and electrophoretic mobility. Both palladium and platinum compounds proved active in the modification of both the secondary and tertiary DNA structures. AFM images showed noticeable modifications of the morphology of the plasmid pBR322 DNA by the compounds probably due to the intercalation of the complexes between base pairs of the DNA molecule. Finally, the palladium complex was tested for antiproliferative activity against three different human tumor cell lines. The results suggest that the palladium complex of formula [Pd(9AA)(μ-Cl)]2 has significant antiproliferative activity, although it is less active than cisplatin.

Photocontrolled DNA Binding of a Receptor-Targeted Organometallic Ruthenium(II) Complex

A photoactivated ruthenium(II) arene complex has been conjugated to two receptor-binding peptides, a dicarba analogue of octreotide and the Arg-Gly-Asp (RGD) tripeptide. These peptides can act as"tumor-targeting devices" since their receptors are overexpressed on the membranes of tumor cells. Both ruthenium-peptide conjugates are stable in aqueous solution in the dark, but upon irradiation with visible light, the pyridyl-derivatized peptides were selectively photodissociated from the ruthenium complex, as inferred by UV-vis and NMR spectroscopy. Importantly, the reactive aqua species generated from the conjugates, [(η6-p-cym)Ru(bpm)(H2O)]2+, reacted with the model DNA nucleobase 9-ethylguanine as well as with guanines of two DNA sequences, 5′dCATGGCT and 5′dAGCCATG. Interestingly, when irradiation was performed in the presence of the oligonucleotides, a new ruthenium adduct involving both guanines was formed as a consequence of the photodriven loss of p-cymene from the two monofunctional adducts. The release of the arene ligand and the formation of a ruthenated product with a multidentate binding mode might have important implications for the biological activity of such photoactivated ruthenium(II) arene complexes. Finally, photoreactions with the peptide-oligonucleotide hybrid, Phac-His-Gly-Met-linker-p5′dCATGGCT, also led to arene release and to guanine adducts, including a GG chelate. The lack of interaction with the peptide fragment confirms the preference of such organometallic ruthenium(II) complexes for guanine over other potential biological ligands, such as histidine or methionine amino acids.

Conjugation of a Ru(II) Arene Complex to Neomycin or to Guanidinoneomycin Leads to Compounds with Differential Cytotoxicities and Accumulation between Cancer and Normal Cells

A straightforward methodology for the synthesis of conjugates between a cytotoxic organometallic ruthenium(II) complex and amino- and guanidinoglycosides, as potential RNA-targeted anticancer compounds, is described. Under microwave irradiation, the imidazole ligand incorporated on the aminoglycoside moiety (neamine or neomycin) was found to replace one triphenylphosphine ligand from the ruthenium precursor [(η6-p-cym)RuCl(PPh3)2]+, allowing the assembly of the target conjugates. The guanidinylated analogue was easily prepared from the neomycin-ruthenium conjugate by reaction with N,N′-di-Boc-N″-triflylguanidine, a powerful guanidinylating reagent that was compatible with the integrity of the metal complex. All conjugates were purified by semipreparative high-performance liquid chromatography (HPLC) and characterized by electrospray ionization (ESI) and matrix-assisted laser desorption-ionization time-of-flight (MALDI-TOF) mass spectrometry (MS) and NMR spectroscopy. The cytotoxicity of the compounds was tested in MCF-7 (breast) and DU-145 (prostate) human cancer cells, as well as in the normal HEK293 (Human Embryonic Kidney) cell line, revealing a dependence on the nature of the glycoside moiety and the type of cell (cancer or healthy). Indeed, the neomycin-ruthenium conjugate (2) displayed moderate antiproliferative activity in both cancer cell lines (IC50 ≈ 80 μM), whereas the neamine conjugate (4) was inactive (IC50 ≈ 200 μM). However, the guanidinylated analogue of the neomycin-ruthenium conjugate (3) required much lower concentrations than the parent conjugate for equal effect (IC50 = 7.17 μM in DU-145 and IC50 = 11.33 μM in MCF-7). Although the same ranking in antiproliferative activity was found in the nontumorigenic cell line (3 2 > 4), IC50 values indicate that aminoglycoside-containing conjugates are about 2-fold more cytotoxic in normal cells (e.g., IC50 = 49.4 μM for 2) than in cancer cells, whereas an opposite tendency was found with the guanidinylated conjugate, since its cytotoxicity in the normal cell line (IC50 = 12.75 μM for 3) was similar or even lower than that found in MCF-7 and DU-145 cancer cell lines, respectively. Cell uptake studies performed by ICP-MS with conjugates 2 and 3 revealed that guanidinylation of the neomycin moiety had a positive effect on accumulation (about 3-fold higher in DU-145 and 4-fold higher in HEK293), which correlates well with the higher antiproliferative activity of 3. Interestingly, despite the slightly higher accumulation in the normal cell than in the cancer cell line (about 1.4-fold), guanidinoneomycin-ruthenium conjugate (3) was more cytotoxic to cancer cells (about 1.8-fold), whereas the opposite tendency applied for neomycin-ruthenium conjugate (2). Such differences in cytotoxic activity and cellular accumulation between cancer and normal cells open the way to the creation of more selective, less toxic anticancer metallodrugs by conjugating cytotoxic metal-based complexes such as ruthenium(II) arene derivatives to guanidinoglycosides.

La Genetica forense: utilidad en la administracion de Justicia, repercusion social y aspectos eticos

Los diccionarios oficiales de la Real Academia de Lengua Española no contienen la palabra forensia, que sin embargo es de amplio uso en el entorno jurídico. El término"forensia" se usa en la mayoría de los casos como equivalente a"ciencia forense" significando la aplicación de la ciencia (en su sentido más amplio) para responder a cuestiones legales y ayudar a la administración de la Justicia. Desde un punto de vista práctico la forensia se utiliza como una vía de autentificación de datos y hechos que tienen interés legal. El uso moderno del término"forensia" en vez de"ciencia forense" es considerado incorrecto por ciertos sectores de la jurisprudencia básicamente por dos motivos: i) la forensia en sentido amplio también implica campos no científicos como el arte y la misma jurisprudencia y ii) por ser el término"forensia" un sinónimo de legal o relacionado con los tribunales.

La Genetica forense: utilidad en la administracion de Justicia, repercusion social y aspectos eticos

Los diccionarios oficiales de la Real Academia de Lengua Española no contienen la palabra forensia, que sin embargo es de amplio uso en el entorno jurídico. El término"forensia" se usa en la mayoría de los casos como equivalente a"ciencia forense" significando la aplicación de la ciencia (en su sentido más amplio) para responder a cuestiones legales y ayudar a la administración de la Justicia. Desde un punto de vista práctico la forensia se utiliza como una vía de autentificación de datos y hechos que tienen interés legal. El uso moderno del término"forensia" en vez de"ciencia forense" es considerado incorrecto por ciertos sectores de la jurisprudencia básicamente por dos motivos: i) la forensia en sentido amplio también implica campos no científicos como el arte y la misma jurisprudencia y ii) por ser el término"forensia" un sinónimo de legal o relacionado con los tribunales.

La vida que quiero: proyectos de vida aplicando psicología positiva y metodologías visuales

Éxito y fracaso escolar conviven diariamente en la escuela. Uno es oportunidad parael otro y viceversa. Combinando la teoría de las fortalezas del carácter, identidad narrativa,teoría de la autodeterminación y otros constructos con metodologías audiovisuales, el programainvita a jóvenes a descubrir sus recursos personales y reescribir su biografía a partir deellos, de modo de finalmente proyectarlos hacia el futuro en un Proyecto de Vida positivo yrealista. Para lograrlo, los alumnos son invitados a auto-observarse, observar a sus compañerosy a entrevistar a sus familiares, aprovechando siempre las representaciones visuales. Estanueva versión de la propia vida queda plasmada en un relato digital, una secuencia de imágenesque retrata la propia vida pasada, presente y futura, sincronizada con un guion que dacuenta del proceso de convertirse en Persona con Fortalezas del Carácter. Se discuten las dificultades,las oportunidades y los desafíos de su implementación en escuelas en Barcelona,Castelldefels y Viladecans.

La prueba Electrónica: Consideraciones

El análisis de la prueba electrónica en nuestro ordenamiento debe de tener en cuenta que dicha fuente de prueba ha sido introducida a partir de la LEC 1/2000, aun cuando la misma ya venía siendo atendida y considerada por nuestra jurisprudencia, así para el caso del fax.Uno de los problemas que nos encontramos es dilucidar el cómo accede al proceso ya sea penal o civil o bien de otras jurisdicciones, y ello no sólo por cuestiones de "logística", sino por razones procesales ya que en muchos casos los tribunales son reacios a que se aporten los soportes informáticos, y tienden más a que el propio contenido de la prueba electrónica se aporte mediante los medios de prueba tradicionales.El objeto del presente trabajo es dar unas pautas al profesional del derecho para que sepa qué caminos puede usar para que la prueba electrónica acceda al proceso con plenas garantías, y gozando de la seguridad jurídico-procesal ante una impugnación de la adversa.

The interaction between mercury(II) and sulfathiazole

The interaction of mercury(II) with sulfathiazole has been analyzed. IR and NMR spectral studies suggest a coordination of Hg(II) with the Nthiazolic atom, unlike related Hg-sulfadrugs compounds. The complex was screened for its activity against Escherichia coli, showing an appreciable antimicrobial activity compared with the ligand.